A thriving pharmaceutical and biotech support industry support company with an already-operating manufacturing facility in Albuquerque has announced plans to substantially expand that facility.
Based in New York, Curia, formerly known as Albany Molecular Research, has just signed off on a deal with the federal government that will result in the stepped-up production of its injectable medicines.
In so doing, the company will build new facility space in the Duke City at 4401 Alexander Boulevard SE designed to provide enhanced ultra-cold storage and automated visual inspection technology.
In a statement, John Ratliff, Curia chief executive officer, said the company’s contract with the U.S. government will not only provide Curia with the opportunity to contribute to the nation’s pandemic response plans, but “also enables us to meet the need to deliver life-changing life science to patients into the future.”
Funding per the agreement is coming through the government’s Biomedical Advanced Research and Development Authority, which is a part of the Department of Health and Human Services, as well as several other federal agencies.
Headquartered in Albany, New York, the company was founded in 1991 and has additional manufacturing plants in Europe and Asia.
By Garry Boulard
